Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Advaxis Inc (ADXS)  
$0.06 0.00 (0.00%) as of 4:30 Fri 6/3


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 66,230,000
Market Cap: 4.11(M)
Last Volume: 362,100 Avg Vol: 361,103
52 Week Range: $0.062 - $0.062
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,317,716 1,317,716
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 586
  Page 17 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-10-27 4 D $3.37 $62,557 D/D (18,563) 117,176     -
   Mauro David J Chief Medical Officer   •       –      –    2014-10-20 4 D $2.88 $85,910 D/D (29,830) 135,170     -
   Mauro David J Chief Medical Officer   •       –      –    2014-10-20 4 A $0.00 $0 D/D 165,000 165,000     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-09-30 4 D $3.36 $60 D/D (18) 73,431     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-09-30 4 A $3.36 $827 D/D 246 73,449     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-09-30 4 D $3.36 $218 D/D (65) 85,196     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-09-30 4 A $3.36 $1,297 D/D 386 85,261     -
   Petit Robert Chief Scientific Officer   •       –      –    2014-09-30 4 D $3.36 $252 D/D (75) 113,523     -
   Petit Robert Chief Scientific Officer   •       –      –    2014-09-30 4 A $3.36 $1,861 D/D 554 113,598     -
   O'connor Daniel Chief Executive Officer   •       •      –    2014-09-30 4 D $3.36 $1,334 D/D (397) 299,169     -
   O'connor Daniel Chief Executive Officer   •       •      –    2014-09-30 4 A $3.36 $6,250 D/D 1,860 299,566     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-09-30 4 D $3.36 $185 D/D (55) 135,739     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-09-30 4 A $3.36 $1,529 D/D 455 135,794     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-08-29 4 D $3.88 $58 D/D (15) 73,203     -
   French Christy Lee VP-Regulatory, Medical Affairs   •       –      –    2014-08-29 4 A $3.88 $826 D/D 213 73,218     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-08-29 4 D $3.88 $217 D/D (56) 84,875     -
   Bonstein Sara Chief Financial Officer   •       –      –    2014-08-29 4 A $3.88 $1,296 D/D 334 84,931     -
   Petit Robert Chief Scientific Officer   •       –      –    2014-08-29 4 D $3.88 $252 D/D (65) 113,044     -
   Petit Robert Chief Scientific Officer   •       –      –    2014-08-29 4 A $3.88 $1,862 D/D 480 113,109     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-08-29 4 D $3.88 $175 D/D (45) 135,339     -
   Mayes Gregory T. Chief Operating Officer   •       –      –    2014-08-29 4 A $3.88 $1,529 D/D 394 135,384     -
   O'connor Daniel Chief Executive Officer   •       •      –    2014-08-29 4 D $3.88 $1,331 D/D (343) 297,706     -
   O'connor Daniel Chief Executive Officer   •       •      –    2014-08-29 4 A $3.88 $6,247 D/D 1,610 298,049     -
   Petit Robert Chief Scientific Officer   •       –      –    2014-08-01 4 D $2.84 $10,521 D/D (2,658) 112,629     -
   Petit Robert Chief Scientific Officer   •       –      –    2014-08-01 4 A $2.84 $2,795 D/D 984 112,789     -
  586 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 17 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us